Related Experiment Videos
Alternative treatment protocols in giardiasis: a pilot study
B U Bulut1, S B Gülnar, D Aysev
1Division of Social Pediatrics, Ankara University School of Medicine, Turkey.
Insights
Ornidazole offers a highly effective, single-dose treatment for giardiasis in children, showing 100% efficacy. This new protocol is a promising, less toxic alternative to conventional giardiasis treatments.
Area of Science:
- Pediatric infectious diseases
- Parasitology
- Clinical pharmacology
Background:
- Giardiasis remains a significant public health concern, particularly in pediatric populations.
- Current treatment protocols for giardiasis often involve multiple doses and can have notable side effects or higher costs.
- There is a need for novel, more accessible, and safer treatment options for giardiasis.
Purpose of the Study:
- To evaluate the efficacy and safety of four distinct treatment protocols for childhood giardiasis.
- To identify a treatment regimen that is less toxic, more cost-effective, and simpler to administer compared to standard therapies.
- To compare ornidazole, metronidazole, and mebendazole in treating giardiasis.
Main Methods:
- A randomized controlled trial involving 48 children diagnosed with giardiasis.
- Four treatment groups were established: mebendazole (100 mg t.i.d. for 1 day), mebendazole (100 mg t.i.d. for 7 days), metronidazole (15 mg/kg for 7 days), and ornidazole (40 mg/kg single dose).
- Treatment efficacy was assessed via microscopic stool examination, and side effects were monitored.
Main Results:
- Ornidazole demonstrated 100% efficacy, followed by metronidazole (92.9%), mebendazole (7 days, 58.3%), and mebendazole (1 day, 41.7%).
- Ornidazole exhibited a favorable safety profile, with only minor side effects (urticaria, vertigo, nausea) reported in 3 children.
- The single-dose ornidazole protocol proved to be the most effective and well-tolerated treatment.
Conclusions:
- Single-dose ornidazole (40 mg/kg) is a highly effective and safe alternative treatment for pediatric giardiasis.
- Further research is recommended to establish the optimal and safest single-dose regimen for ornidazole.
- Novel treatment strategies like single-dose ornidazole can improve patient compliance and treatment outcomes for giardiasis.
Abstract:
The aim of the study was to test new treatment protocols for giardiasis, which are less toxic, cheaper, and easier to use than the conventional treatment. 48 children who had been diagnosed as having giardiasis in a health-screening program involving 2 schools, were randomized to receive four different treatment protocols. The children were split into 4 treatment groups: I, mebendazole 100 mg t.i.d. for 1 day; II, mebendazole 100 mg t.i.d. for 7 days; III, metronidazole 15 mg/kg as one dose for 7 days; and IV, ornidazole 40 mg/kg as a single dose. The results were evaluated by microscopic examination of stools. The responses to the treatments revealed that the effectiveness of ornidazole was 100%, metronidazole 92.9%, mebendazole for 7 days 58.3%, and mebendazole for 1 day 41.7%. Minor side-effects were seen in only 3 children receiving ornidazole: 1 had urticaria, while the other 2 suffered from vertigo and nausea. The results of this study show that ornidazole as a single dose can be used as an alternative protocol for treating giardiasis. Further studies should be done to determine the safest effective total single dose.